Egalet (EGLT) is using injection molding technology to package frequently abused opiate drugs like morphine in pills that can be ground down or melted for abuse. Longer term they plan to introduce pills that yield improved drug release over existing branded and generic packages as well.
The company hopes to complete a ~40M IPO which implies a ~$170M market value. Below we list a few pros and cons as well as excerpts from the full EGLT roadshow transcript and as usual we have the EGLT . . .